Editorial Board Member - JHBD
David J. MacEwan
ProfessorDepartment of Molecular & Clinical Pharmacology
Institute of Translational Medicine
University of Liverpool
United Kingdom
BIOGRAPHY:
Dr. MacEwan studied Pharmacology at Glasgow and Edinburgh Universities undertaking a PhD with Dr. Rory Mitchell at the MRC Brain Metabolism Unit, University of Edinburgh. A further postdoctoral stint at Glasgow was followed by faculty position in 1996 at the University of Aberdeen. He became the Professor of Pharmaceutical Cell Biology at the University of East Anglia in 2005, before moving to his current position of Chair in Molecular Pharmacology in the Department of Molecular & Clinical Pharmacology at the University of Liverpool – the UK’s largest Pharmacology department. He has received many honors and awards. He has received two patents.
RESEARCH INTERESTS:
Dr. MacEwan’s research interests include:
Signal transduction mechanisms controlling cell death, proliferative and toxicological responses in human leukemia. With wide-ranging interests in cell surface receptor mechanisms, kinase pathway systems and transcription factor control mechanisms, Dr MacEwan is interested in understanding drug-resistance mechanisms and drug-toxicity mechanisms to further clinical therapeutic advances in human leukemias.
Other Editorial Board Members - JHBD
Andrew W. Taylor-Robinson
School of Medical & Applied Sciences
Central Queensland University
Australia
Fadia Mostafa Attia
Faculty of Medicine
Suez Canal University
Egypt
Konstantin N Konstantinov
Department of Internal Medicine
University of New Mexico
United States
